JPS6240329B2 - - Google Patents

Info

Publication number
JPS6240329B2
JPS6240329B2 JP59105653A JP10565384A JPS6240329B2 JP S6240329 B2 JPS6240329 B2 JP S6240329B2 JP 59105653 A JP59105653 A JP 59105653A JP 10565384 A JP10565384 A JP 10565384A JP S6240329 B2 JPS6240329 B2 JP S6240329B2
Authority
JP
Japan
Prior art keywords
theaspiran
formula
mixture
flavor
absorption
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP59105653A
Other languages
Japanese (ja)
Other versions
JPS601119A (en
Inventor
Naegeri Piitaa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Givaudan SA
Original Assignee
L Givaudan and Co SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by L Givaudan and Co SA filed Critical L Givaudan and Co SA
Publication of JPS601119A publication Critical patent/JPS601119A/en
Publication of JPS6240329B2 publication Critical patent/JPS6240329B2/ja
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11BPRODUCING, e.g. BY PRESSING RAW MATERIALS OR BY EXTRACTION FROM WASTE MATERIALS, REFINING OR PRESERVING FATS, FATTY SUBSTANCES, e.g. LANOLIN, FATTY OILS OR WAXES; ESSENTIAL OILS; PERFUMES
    • C11B9/00Essential oils; Perfumes
    • C11B9/0069Heterocyclic compounds
    • C11B9/0073Heterocyclic compounds containing only O or S as heteroatoms
    • C11B9/0088Spiro compounds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/94Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom spiro-condensed with carbocyclic rings or ring systems, e.g. griseofulvins

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Wood Science & Technology (AREA)
  • Fats And Perfumes (AREA)
  • Cosmetics (AREA)
  • Seasonings (AREA)

Description

【発明の詳现な説明】[Detailed description of the invention]

本発明は芳銙組成物およびたたはフレヌバ
組成物に関する。さらに詳现には、本発明は䞍可
欠の芳銙付䞎成分およびたたはフレヌバ付䞎
成分ずしおテアスピランtheaspiranを含む芳
銙組成物およびたたはフレヌバ組成物に関す
る。 埌蚘の図匏䞭に瀺す匏のテアスピラン〔・
・10・10−テトラメチル−−オキサ−スピロ
〔・〕−デカ−−゚ン〕は「Tetrahedron
letters」、19951969に開瀺され、公知化合物
である。この化合物が特別の官胜的性質を有し、
特に芳銙付䞎物質およびたたはフレヌバ付䞎
物質ずしお適しおいるこずが、本発明により芋出
された。 事実、テアスピランは皮々の粟油、䟋えばラズ
ベリ油たたは黄色パツシペンフルヌツ油䞭に非垞
に僅かな濃床で怜出されおいる〔Helv.Chim.
Acta 57、1301197455、19161972
54、18811971参照〕。しかし、テアスピラン
が芳銙付䞎物質およびたたはフレヌバ付䞎物
質ずしお極めお適圓であるず認められたこずは驚
くべきこずである。それは、䞊蚘の発衚報告はい
ずれもテアスピランの特殊な官胜的性質に぀いお
䜕も述べおいないからである。 埓぀お本発明はこれに察する䞀芳点においお
は、必須の芳銙付䞎成分およびたたはフレヌ
バ付䞎成分ずしお実際䞊玔粋のたたは混合物のテ
アスピランテアスピランを含む倩然産混合物を
陀倖するを含む芳銙組成物およびたたはフ
レヌバ組成物に関する。 実際䞊玔粋なテアスピランずは、䞊蚘の倩然油
出油䞭にテアスピラン以倖に随䌎物質を含んでい
ないテアスピランを特に指すものである。本発明
の範囲内における実際䞊玔粋なテアスピランずし
お、䟋えば合成的に補造されたテアスピランがあ
る。 本発明により芳銙付䞎物質およびたたはフ
レヌバ付䞎物質ずしお䜿甚されるテアスピランは
特別の新鮮な果実ようの芳銙たたはフレヌバ性が
顕著である。特に関心が持たれるのは、ベリヌ
様、グリヌンノヌトおよび濃床の䞊昇に぀れお珟
われる甘味性のりツデむニナアンスである。埓぀
おテアスピランは䟋えば化粧品石けん、軟こ
う、おしろいなど、掗剀、食品、嗜奜品ず飲料
類など各皮補品の銙気づけたたはフレヌバづけに
䜿甚されるが、テアスピランは単独に䜿甚しない
で他の芳銙付䞎物質たたはフレヌバ付䞎物質を含
む組成物の圢で䜿甚するこずが奜たしい。 別の点では、本発明は、実質的に玔粋の又は混
合物のテアスピランを含む倩然混合物を陀く
テアスピランを既知の芳銙組成物およびたた
はフレヌバ組成物ぞ添加するか或いはこのテア
スピランを芳銙組成物およびたたはフレヌバ
組成物の成分ずしお適した倩然たたは合成化合物
たたはその混合物ず混合するこずによりなる、芳
銙組成物およびたたはフレヌバ組成物の補造
方法に関する。 テアスピランは著しい倩然のノヌトをも぀おい
るので、公知組成物䟋えばシプレ型の組成物を改
質するためのオドラントずしお特に適しおいる。
䟋えばネロリノヌトやロヌズノヌトなどのフラワ
ヌノヌトずの組合せに極めお良く適合する。 本組成物䞭におけるテアスピランの濃床は䜿甚
目的に応じお広範囲内で倉り埗る。䟋えば玄重
量掗剀䞭でず玄15重量アルコヌル溶液
ずしおずの範囲内で䜿甚できる。銙料ベヌスた
たは濃瞮油では、勿論も぀ず濃床が高くなる。 フレヌバ付䞎物質ずしおのテアスピランは、䟋
えば食品ペヌグルトやケヌキなど、嗜奜品
タバコなどおよび飲料レモネヌドなどに
おける果実やベリヌフレヌバを生成たたは改良、
匷化促進或いは修正するために䜿甚できる。 実際䞊玔粋な、特に合成的に補造されたテアス
ピランの著しいフレヌバ特性によ぀お、テアスピ
ランは䜎濃床で䜿甚できる。それの適量は、最終
補品すなわち芳銙づけした食品、嗜奜品たたは飲
料においお0.00001ppm〜1ppmなお奜適には
0.001ppm〜0.1ppmの範囲内にある。 テアスピランを甚いお生成される幟぀かの効果
を次の衚にたずめおある。
The present invention relates to aroma and/or flavor compositions. More particularly, the present invention relates to fragrance and/or flavor compositions comprising theaspiran as an essential aroma-imparting and/or flavor-imparting ingredient. Theaspiran [2.
6,10,10-tetramethyl-1-oxa-spiro[4,5]-dec-6-ene]
letters”, 1995 (1969), and is a known compound. This compound has special organoleptic properties,
It has been found according to the invention that they are particularly suitable as aromatizing and/or flavoring substances. In fact, theaspiran is found in very small concentrations in various essential oils, such as raspberry oil or yellow passion fruit oil [Helv.Chim.
Acta 57 , 1301 (1974); 55 , 1916 (1972);
54 , 1881 (1971)]. However, it is surprising that theaspiran has been found to be highly suitable as an aromatizing and/or flavoring substance. This is because none of the above publications mention anything about the special sensory properties of theaspiran. The present invention therefore provides in one aspect to this, a fragrance composition comprising as an essential aromatizing and/or flavoring ingredient theaspiran (excluding naturally occurring mixtures containing theaspiran), practically pure or in a mixture; (or) relating to flavor compositions. Practically pure theaspiran specifically refers to theaspiran which does not contain any accompanying substances other than theaspiran in the above-mentioned natural oil extraction. Practically pure theaspiran within the scope of the present invention includes, for example, synthetically produced theaspiran. Theaspiran used according to the invention as aromatizing and/or flavoring substance is notable for its particular fresh fruity aroma or flavour. Of particular interest are the berry-like, green notes and the sweet, mellow nuances that develop as the concentration increases. Therefore, theaspiran is used for aromatizing or flavoring various products such as cosmetics (soaps, ointments, face powder, etc.), detergents, foods, luxury goods and beverages, but theaspiran is not used alone and can be used to impart other fragrances. Preferably, it is used in the form of a composition containing substances or flavoring substances. In another respect, the present invention provides for substantially pure or mixed (other than natural mixtures containing theaspiran)
by adding theaspiran to known aroma and/or flavor compositions or by mixing the theaspiran with natural or synthetic compounds or mixtures thereof suitable as components of the aroma and/or flavor compositions. , relates to a method for producing aroma compositions and/or flavor compositions. Since theaspiran has a pronounced natural note, it is particularly suitable as an odorant for modifying known compositions, such as those of the chypre type.
For example, it is extremely suitable for combinations with flower notes such as neroli and rose notes. The concentration of theaspiran in the composition can vary within a wide range depending on the intended use. For example, a range of about 1% by weight (in detergents) to about 15% by weight (as alcoholic solutions) can be used. With perfume bases or concentrated oils, the concentration will of course be higher. Theaspiran as a flavoring substance can be used, for example, to produce or improve fruit and berry flavors in foods (such as yoghurt and cakes), luxury goods (such as cigarettes) and beverages (such as lemonade).
Can be used to enhance or modify. The remarkable flavor properties of virtually pure, especially synthetically produced, theaspiran allow it to be used in low concentrations. The appropriate amount thereof is preferably 0.00001ppm to 1ppm in the final product, i.e. aromatized food, luxury food or beverage.
It is within the range of 0.001ppm to 0.1ppm. Some of the effects produced using theaspiran are summarized in the following table.

【衚】 テアスピランは、フレヌバ組成物に䜿甚される
成分ず混合するか或いは普通の方法でこのような
フレバラントに添加するこずができる。本発明に
より䜿甚されるフレバラントずは、呚知方法で食
品䞭に皀釈たたは分散し埗るフレヌバ組成物をい
う。これらフレバラントは公知方法によ぀お、溶
液、ペヌストたたは粉末などの通垞の䜿甚圢態に
倉換できる。生成物は噎霧也燥、真空也燥たたは
凍結也燥できる。 前蚘した通垞の䜿甚圢態を調補する堎合、次の
ような担䜓物質、濃厚剀、フレヌバ改良剀、補助
成分等の物質を挙げるこずができる。 アラビダガム、トラガカントガム、塩類たたは
ビヌル酵母、アルギン酞、カラゲニンたたは類䌌
の吞収剀、むンドヌル類、マルトヌル、ゞ゚ナヌ
ル類、スパむスオレオレゞン、タバコフレヌバ、
クロヌブ、ゞアセチル、ク゚ン酞ナトリりム、グ
ルタミン酞モノナトリりム、むノシン−5′−モノ
燐酞ゞナトリりムIMP、グアノシン−−リ
ン酞ゞナトリりムGMP、特別のフレヌバ付䞎
物質、氎、゚タノヌル、プロピレングリコヌルお
よびグリセリン。 前蚘の説明から分るが、本発明の範囲内に、既
述した芳銙組成物およびたたはフレヌバ組成
物、或いは実際䞊玔粋のたたは混合物のテアスピ
ランテアスピランを含む倩然産混合物を陀倖す
るを物質に適甚し或いは物質に添加するこずに
より、この物質ぞ芳銙およびたたはフレヌバ
を付䞎する方法をも含むものである。 本発明はさらに、埌蚘の反応匏図䞭の匏の
−・・−トリメチル−−シクロヘキセ
ン−−むリデン−ブタン−−オヌルを酞で
凊理するこずよりなる、テアスピランの新芏補造
方法に関する。 特に適切な酞ずしおは、プロトン酞䟋えば無機
ず有機のプロトン酞すなわち硫酞、リン酞、
−トル゚ンスルホン酞などたたはルむス酞
BF3、SnCl4、ZnCl2などがある。−トル゚
ンスルホン酞が奜適なプロトン酞である。 匏の−・・−トリメチル−−シ
クロヘキセン−−むリデン−ブタン−−オ
ヌルを環化しお匏のテアスピランずするには、
溶媒を甚いお或いは甚いないで行なうこずができ
る。適圓な溶媒は、䞍掻性溶媒䟋えばヘキサン、
ベンれン、ニトロメタン、塩玠化炭化氎玠クロ
ロホルムなどおよび゚ヌテル類ゞオキサンな
どである。ベンれンやトル゚ンは奜適な溶媒で
ある。反応枩床は重芁でなく、䞊蚘の凊理は宀枩
でも、たた高枩や䜎枩でも行なうこずができる。 次の図匏においおテアスピランを酞化し、匏
のフレヌバ付䞎物質テアスピランを生成するのは
公知技術である䟋えば米囜特蚱明现曞第
3645755号参照から、本発明方法もたたテアス
ピランぞの有利な到達法であるず云える。公知方
法によるテアスピラン䞊蚘方法に埓぀お補造し
たものを酞化しおテアスピランを補造する方法
も、本発明の䞀郚をなすものである。
TABLE Theaspiran can be mixed with the ingredients used in flavor compositions or added to such flavorants in a conventional manner. Flavorants used according to the present invention refer to flavor compositions that can be diluted or dispersed in food products in a known manner. These flavorants can be converted by known methods into the customary forms of use, such as solutions, pastes or powders. The product can be spray dried, vacuum dried or freeze dried. When preparing the above-mentioned usual usage forms, mention may be made of the following substances such as carrier substances, thickeners, flavor improvers, and auxiliary ingredients. gum arabic, gum tragacanth, salts or brewer's yeast, alginic acid, carrageenan or similar absorbents, indoles, maltol, dienals, spice oleoresins, tobacco flavors,
Cloves, diacetyl, sodium citrate, monosodium glutamate, disodium inosine-5'-monophosphate (IMP), disodium guanosine-5-phosphate (GMP), special flavoring substances, water, ethanol, propylene glycol and Glycerin. As can be seen from the foregoing description, it is within the scope of the present invention to use the aromatic and/or flavor compositions already mentioned, or theaspiran (excluding naturally occurring mixtures containing theaspiran) in virtually pure or mixed form. It also includes methods of imparting aroma and/or flavor to a substance by applying or adding it to the substance. The present invention further provides formula 4 in the reaction scheme diagram below.
The present invention relates to a new method for producing theaspiran, which comprises treating -(2,6,6-trimethyl-2-cyclohexen-1-ylidene)-butan-2-ol with an acid. Particularly suitable acids include protic acids such as inorganic and organic protic acids (i.e. sulfuric acid, phosphoric acid, p
-toluenesulfonic acid, etc.) or Lewis acids ( BF3 , SnCl4 , ZnCl2 , etc.). p-Toluenesulfonic acid is a preferred protic acid. To cyclize 4-(2,6,6-trimethyl-2-cyclohexen-1-ylidene)-butan-2-ol of the formula to theaspiran of the formula,
It can be carried out with or without a solvent. Suitable solvents include inert solvents such as hexane,
These are benzene, nitromethane, chlorinated hydrocarbons (such as chloroform) and ethers (such as dioxane). Benzene and toluene are suitable solvents. The reaction temperature is not critical, and the above treatment can be carried out at room temperature, as well as at higher or lower temperatures. It is known in the art to oxidize theaspiran in the following scheme to produce the flavoring substance theaspiran of the formula (e.g. U.S. Pat.
3645755), it can be said that the method of the present invention is also an advantageous way to reach theaspiran. A method of producing theaspiran by oxidizing theaspiran (produced according to the method described above) by known methods also forms part of the present invention.

【衚】 䞊蚘の反応匏図に぀いお云うず、匏のアルコ
ヌルは匏のアシロキシ化合物から埗られるが、
この化合物は匏のβ−むオノンから埗られる。
匏のアシロキシ化合物は䟋えば、氎玠化硌玠リ
チりム、氎玠化硌玠ナトリりム、氎玠化硌玠化カ
リりム、氎玠化リチりムアルミニりムなどの錯氎
玠化物を甚いお匏のアルコヌルぞ倉換できる。
この反応は溶媒ずしおアルコヌル類䟋えばアルカ
ノヌル、アルコヌル゚ヌテル混合液たたぱヌテ
ルにお行なうこずが有利である。反応枩床は重芁
でないが、玄−10℃〜80℃の枩床で行なうのが奜
たしい。 匏のアシロキシ化合物は、匏のβ−むオノ
ンに゚ノヌルアシレヌトを反応させお埗られる。
適切な゚ノヌルアシレヌトは、酢酞む゜プロペニ
ル、酢酞む゜ブテニルなどである。匏のアシロ
キシ化合物を生成するには、觊媒量の酞䟋えば
前蚘の酞のうちいずれかの存圚䞋に行なうのが
有利である。−トル゚ンスルホン酞が奜適な酞
である。゚ノヌルアシレヌトを過剰に䜿甚するの
が有利であり、この化合物は溶媒ずしおも働くも
のである。この反応は奜たしくは、反応混合物の
還流枩床で行ない、反応䞭に生成するケトン酢
酞む゜プロピニルの堎合にはアセトンを連続的
に留去する。 匏は、可胜性ある぀の立䜓異性䜓を含み、
匏は党郚で぀の立䜓異性䜓を含むこずが理解
されよう。同様に匏ず匏は぀ず぀のゞアス
テレオマヌ化合物すなわち察の鏡像䜓を含
んでいる。 次に掲げる䟋は本発明を説明するためのもので
ある。 䟋 参考䟋 β−むオノン96を酢酞む゜プロペニル500ml
に溶解しお、−トル゚ンスルホン酞䞀氎塩0.6
で凊理した。この混合物を䞍掻性ガス雰囲気䞋
還流枩床で24時間撹拌した。過剰の酢酞む゜プロ
ペニルを真空䞋で反応混合物から留去し枩床≊
50゜おから、混合物をヘキサンで数回凊理し、
残留した酢酞む゜プロペニルを陀去し、再び濃瞮
した。このようにしお赀耐色の−・・
−トリメチル−−シクロヘキセン−−むリデ
ン−−アセトキシ−ブテ−−゚ン匏、
アセチル108を埗た。 UV吞収゚タノヌルλnax276n、logε
4.265。 IR吞収フむルム1755、1650、1580、
1370、12201205、11501140、1040、1020、
945、925、885875865、818cm-1。 NMR吞収CDCl3TMSΎ6.65−5.85
2H、、Ύ5.781H、ブロヌド、Ύ
2.20ず2.153H、それぞれ、Ύ2.05
3H、ブロヌド、Ύ1.853S、ナロヌ
、Ύ1.28ppm6H、 MS質量分析法234、フラグメント
192、177、159、149、136、121、107、91、
81、77、71、65、55、43基本ピヌク、 匏で瀺される埗られた粗アセトキシ化合物
108を96゚タノヌル400mlに溶解し、次に
96゚タノヌル600ml䞭の氎玠化硌玠ナトリりム
20の懞濁液ぞ僅かに冷华し぀぀20〜30℃で10分
間以内に滎䞋した。次にこの混合液を熱しお僅か
な還流を起こし、この枩床で15分間撹拌した。反
応の終結は、濃黄からレモン・む゚ロヌぞの倉色
によ぀お怜知できる。宀枩に冷华した混濁混合物
を飜和塩化アンモニりム溶液−氷の混合物に泚
ぎ、これをヘキサンで抜出した。通垞の氎掗によ
぀お䞭性になるたで掗い、無氎硫酞ナトリりムで
也燥した埌、溶媒を真空蒞発させた。粗−
・・−トリメチル−−シクロヘキセン
−−むリデン−ブタン−−オヌル匏
96を埗た。 UV吞収゚タノヌルλnax239nlogε
。 IR吞収フむルム3300、13801370
1360、1125、1085、950、880、830cm-1。 NMR吞収CDCl3TMSΎ5.71H、ブロ
ヌド、Ύ5.41H、そしおHz、
Ύ3.91H、そしおHz、Ύ2.55
2H、ブロヌドそしおHz、Ύ1.85
3H、ナロヌ、Ύ1.253H、そしお
Hz、Ύ1.23ppm6H、。 MS194、フラグメント189、161、
150、135基本、121、107、93、79、69、55、
45、41。 匏の粗補アルコヌル96を、−トル゚ンス
ルホン酞䞀氎塩の存圚䞋無氎ベンれン1.3
䞭で10時間還流加熱した。この溶液を重炭酞塩の
冷飜和溶液ぞ泚入しヘキサンで抜出した。抜出液
を䞭性ずなるたで掗浄し硫酞ナトリりムで也燥し
た埌、溶媒を真空蒞発した。匏の耐色油状の粗
テアスピラン96を第䞀ランニングおよび残滓か
ら短冷华管蒞留によ぀お分離した。収量匏の
テアスピラン77、沞点75℃0.2mmHg、D 20
1.492。 IR吞収フむルム1475、1455、1380、
1360、1285、1195、11601150、1130、1110
108510801060、1040、1005、990、975、
930、910900、880、825、775、725cm-1。 NMR吞収CDCl3TMS異性䜓 Ύ5.251H、ナロヌ、Ύ4.11H、ブ
ロヌド、Ύ1.753H、ナロヌ、Ύ
1.263H、そしおHz、Ύ0.95およ
び0.88ppmそれぞれ3H、。 異性䜓 Ύ5.4011H、ナロヌ、Ύ4.051H、
ブロヌド、Ύ1.73H、ナロヌ、Ύ
1.283H、そしおHz、Ύ1.00およ
び0.88ppmそれぞれ3H、。 MS194、フラグメント179、151、
151、135基本ピヌク、123、109、96、82、
77、67、55、41。 䟋 参考䟋 テアスピラン5.730ミリモルを無氎第䞉
玚ブタノヌル60mlに溶解し、−ブチルクロメヌ
ト溶液〔CrO3150、第䞉玚ブタノヌル400mlお
よび無氎酢酞140ml〕120mlCrO3箄30ミリモル
に盞圓を甚いお40℃で時間以内で凊理した。
次にこの混合液を40℃で撹拌した。−ブチルク
ロメヌト溶液をさらに20ml、日埌に滎䞋し、10
日埌にそれず同じ量を添加した。合蚈16日埌に混
合液の凊理を終えた。この混合液を塩化メチレン
に加え、これを氷で芆い、亜硫酞塩ず重亜硫
酞塩の混合溶液〔重亜硫酞ナトリりム40、亜硫
酞ナトリりム50、氎〕を加えお時間
撹拌した。次にこの混合液が䞭性ずなるたで重炭
酞ナトリりム泡和溶液で掗浄し、次に氎で掗浄
し、硫酞マグネシりムで也燥しおから蒞発也固し
た。黄色の油3.0を埗、これをカラムクロマト
グラフむにより、〜10の゚ヌテルを含むヘキ
サン゚ヌテルの混合液を甚いお、30倍量のシリ
カゲル粒床0.063〜0.200mmで粟補した。沞点
88℃0.12mmHgのテアスピランの収率は20で
あ぀た。 UV吞収゚タノヌルλnax235nε
11740。 MS208、193、175、152、110、
96、82、69、55、41。 IR吞収フむルム1675、1630、1480、
1450、13908070、1345、1310、1280、
1270、1160、1090、980、920、890cm-1。 NMR吞収CDCl3TMSΎ5.72においお
1Hナロヌ四重線そしお1.5Hz、Ύ4.2
゜䞭心䜍眮においお1H倚重線、Ύ
2.01およびΎ1.99においお3H぀のゞアス
テレオマヌのそれぞれに぀いお単線、Ύ
1.30においお3H二重線そしおHz、Ύ
0.99ず1.02においお6H䞀察にな぀おいるゞ
メチル矀に぀いお単線。 䟋 
[Table] Regarding the above reaction diagram, the alcohol of the formula can be obtained from the acyloxy compound of the formula,
This compound is obtained from the formula β-ionone.
An acyloxy compound of the formula can be converted to an alcohol of the formula using, for example, a complex hydride such as lithium borohydride, sodium borohydride, potassium borohydride, lithium aluminum hydride.
The reaction is advantageously carried out in alcohols such as alkanols, alcohol-ether mixtures or ethers as solvent. The reaction temperature is not critical, but it is preferably carried out at a temperature of about -10°C to 80°C. The acyloxy compound of the formula can be obtained by reacting the β-ionone of the formula with enol acylate.
Suitable enol acylates include isopropenyl acetate, isobutenyl acetate, and the like. The production of acyloxy compounds of the formula is advantageously carried out in the presence of a catalytic amount of an acid, such as any of the acids mentioned above. p-Toluenesulfonic acid is a preferred acid. It is advantageous to use an excess of enol acylate, this compound also acting as a solvent. This reaction is preferably carried out at the reflux temperature of the reaction mixture, and the ketone (acetone in the case of isopropynyl acetate) formed during the reaction is continuously distilled off. The formula includes four possible stereoisomers,
It will be understood that the formula includes a total of four stereoisomers. Similarly, formula and formula include two diastereomeric compounds (ie, two pairs of enantiomers). The following examples are intended to illustrate the invention. Example 1 (Reference example) 96g of β-ionone and 500ml of isopropenyl acetate
Dissolved in p-toluenesulfonic acid monohydrate 0.6
It was treated with g. The mixture was stirred at reflux temperature for 24 hours under an inert gas atmosphere. Excess isopropenyl acetate is distilled off from the reaction mixture under vacuum (temperature ≀
50°), then treated the mixture with hexane several times,
The remaining isopropenyl acetate was removed and concentrated again. In this way, the reddish-brown 4-(2, 6, 6
-trimethyl-2-cyclohexen-1-ylidene)-2-acetoxy-but-2-ene (formula,
108 g of R=acetyl were obtained. UV absorption (ethanol): λ nax = 276 nm, logε
=4.265. IR absorption (film): 1755, 1650, 1580,
1370, 1220/1205, 1150/1140, 1040, 1020,
945, 925, 885/875/865, 818cm -1 . NMR absorption (CDCl 3 + TMS): ή = 6.65−5.85
(2H, m), ÎŽ=5.78 (1H, broad t), ÎŽ=
2.20 and 2.15 (3H, s each), ÎŽ = 2.05
(3H, broad s), ÎŽ=1.85 (3S, narrow m), ÎŽ=1.28ppm (6H, s). MS (mass spectrometry): m/e: 234, fragment
192, 177, 159, 149, 136, 121, 107, 91,
81, 77, 71, 65, 55, 43 = basic peak, The obtained crude acetoxy compound (108 g) shown by the formula was dissolved in 400 ml of 96% ethanol, and then
Sodium borohydride in 600ml of 96% ethanol
It was added dropwise to 20 g of suspension within 10 minutes at 20-30° C. with slight cooling. The mixture was then heated to slight reflux and stirred at this temperature for 15 minutes. The end of the reaction can be detected by a color change from deep yellow to lemon yellow. The cloudy mixture, cooled to room temperature, was poured into a saturated ammonium chloride solution-ice mixture and extracted with hexane. After washing until neutral with regular water washing and drying over anhydrous sodium sulfate, the solvent was evaporated in vacuo. Coarse 4-
(2,6,6-trimethyl-2-cyclohexen-1-ylidene)-butan-2-ol (formula)
Obtained 96g. UV absorption (ethanol): λ nax : 239 nm (logε
=4). IR absorption (film): 3300, 1380/1370/
1360, 1125, 1085, 950, 880, 830cm -1 . NMR absorption (CDCl 3 +TMS): ÎŽ = 5.7 (1H, broad t), ÎŽ = 5.4 (1H, t and J = 7Hz),
ÎŽ=3.9 (1H, m and J=6Hz), ÎŽ=2.55
(2H, broad t and J=7Hz), ÎŽ=1.85
(3H, narrow m), ÎŽ=1.25 (3H, d and J
= 6Hz), ÎŽ = 1.23ppm (6H, s). MS: m/e: 194, fragments 189, 161,
150, 135 = basic, 121, 107, 93, 79, 69, 55,
45, 41. 96 g of the crude alcohol of the formula was mixed with 1.3 g of anhydrous benzene in the presence of 1 g of p-toluenesulfonic acid monohydrate.
The mixture was heated under reflux for 10 hours. The solution was poured into a cold saturated solution of bicarbonate and extracted with hexane. The extract was washed until neutral, dried over sodium sulfate, and then the solvent was evaporated in vacuo. 96 g of crude theaspiran as a brown oil of the formula were separated from the first run and the residue by short condenser distillation. Yield: 77g of theaspiran of the formula, boiling point = 75℃/0.2mmHg, n D 20
=1.492. IR absorption (film): 1475, 1455, 1380,
1360, 1285, 1195, 1160/1150, 1130, 1110/
1085/1080/1060, 1040, 1005, 990, 975,
930, 910/900, 880, 825, 775, 725cm -1 . NMR absorption (CDCl 3 + TMS): Isomer A ÎŽ = 5.25 (1H, narrow m), ÎŽ = 4.1 (1H, broad m), ÎŽ = 1.75 (3H, narrow m), ÎŽ =
1.26 (3H, d and J = 6 Hz), ÎŽ = 0.95 and 0.88 ppm (3H, s, respectively). Isomer B ÎŽ = 5.40 (11H, narrow m), ÎŽ = 4.05 (1H,
Broad m), ÎŽ=1.7 (3H, narrow m), ÎŽ=
1.28 (3H, d and J = 6 Hz), ÎŽ = 1.00 and 0.88 ppm (3H, s, respectively). MS: m/e: 194, fragments 179, 151,
151, 135 = basic peak, 123, 109, 96, 82,
77, 67, 55, 41. Example 2 (Reference Example) Dissolve 5.7 g (30 mmol) of theaspiran in 60 ml of anhydrous tertiary butanol, and dissolve 120 ml of t-butylchromate solution [150 g of CrO 3 , 400 ml of tertiary butanol, and 140 ml of acetic anhydride] (approximately 30 mmol of t -butyl chromate). (equivalent to mmol) at 40° C. within 2 hours.
This mixture was then stirred at 40°C. Another 20 ml of t-butyl chromate solution was added dropwise after 8 days.
The same amount was added a day later. The treatment of the mixture was completed after a total of 16 days. This mixed solution was added to 1 part of methylene chloride, which was covered with ice, and 1 part of a mixed solution of sulfite and bisulfite [40 g of sodium bisulfite, 50 g of sodium sulfite, 1 part of water] was added and stirred for 1 hour. The mixture was then washed with a foaming sodium bicarbonate solution until neutral, then water, dried over magnesium sulfate and evaporated to dryness. 3.0 g of a yellow oil was obtained, which was purified by column chromatography on 30 volumes of silica gel (particle size 0.063-0.200 mm) using a hexane/ether mixture containing 5-10% ether. boiling point
The yield of theaspiran at 88°C/0.12mmHg was 20%. UV absorption (ethanol): λ nax = 235 nm (ε =
11740). MS: m/e: 208=M+, 193, 175, 152 , 110,
96, 82, 69, 55, 41. IR absorption (film): 1675 , 1630 , 1480 ,
1450 , 1390/80/70, 1345, 1310, 1280,
1270, 1160, 1090 , 980, 920, 890cm -1 . NMR absorption (CDCl 3 + TMS): at ÎŽ=5.72
1H (narrow quartet and J=1.5Hz), ÎŽ=4.2
1H (multiple line) at ° (center position), Ύ=
3H (single line for each of the two diastereomers) at 2.01 and ÎŽ = 1.99, ÎŽ =
3H (double and J=6Hz) at 1.30, ÎŽ
= 6H at 0.99 and 1.02 (single line for paired dimethyl groups). Example 3

【衚】 組成物は組成物よりも遥かに匷い果物よう
のアロマを有し、たた組成物よりも実質䞊長く
粘着を保持した。 䟋 
Table: Composition B had a much stronger fruity aroma than Composition A and also retained its tack substantially longer than Composition A. Example 4

【衚】 組成物は、埓来のバニラアロマである組成物
ずは官胜的に異なり、極めお有利であ぀た。特
に、テアスピランは匱いりツデむ、フルヌツノヌ
トを䞎えるので、バニラのフラグランスを著しく
軟らげた。 䟋 
[Table] Composition B was organoleptically different from Composition A, a traditional vanilla aroma, and was highly advantageous. In particular, theaspiran significantly softened the vanilla fragrance as it imparted a weak, dull, fruity note. Example 5

【衚】【table】

【衚】  
テアスピラン(゚タノヌル1溶液) − 10
[Table] A B
Theaspiran (1% ethanol solution) - 10

Claims (1)

【特蚱請求の範囲】  実際䞊玔粋な圢又は混合物の圢テアスピラ
ン含有倩然混合物を陀くのテアスピラン、なら
びに他の公知の銙り付䞎成分およびフレヌバ付䞎
成分を含有するこずを特城ずする、芳銙および
たたはフレヌバ改良、匷化、促進又は修正組
成物。  合成的に補造したテアスピランを含有する、
特蚱請求の範囲第項蚘茉の組成物。
[Claims] 1. An aromatic and flavoring agent characterized in that it contains theaspiran in practically pure form or in the form of a mixture (excluding theaspiran-containing natural mixtures), as well as other known odor-imparting and flavor-imparting ingredients. (or) a flavor-improving, enhancing, promoting or modifying composition. 2 Containing synthetically produced theaspiran,
A composition according to claim 1.
JP59105653A 1975-03-11 1984-05-24 Fragrant composition Granted JPS601119A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CH3053/75 1975-03-11
CH305375A CH613379A5 (en) 1975-03-11 1975-03-11 Perfuming and/or flavouring compositions
CH16871/75 1975-12-30

Publications (2)

Publication Number Publication Date
JPS601119A JPS601119A (en) 1985-01-07
JPS6240329B2 true JPS6240329B2 (en) 1987-08-27

Family

ID=4247550

Family Applications (1)

Application Number Title Priority Date Filing Date
JP59105653A Granted JPS601119A (en) 1975-03-11 1984-05-24 Fragrant composition

Country Status (2)

Country Link
JP (1) JPS601119A (en)
CH (1) CH613379A5 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE112006002442T5 (en) 2005-09-13 2008-07-17 Takasago International Corp. Process for the preparation of optically active theaspirane
JP5745805B2 (en) * 2010-09-28 2015-07-08 株匏䌚瀟 資生堂 Use of sedative effect imparting agent and sedative and 2R-teaspirane
JP2012211099A (en) * 2011-03-31 2012-11-01 Takasago Internatl Corp Fragrance composition for cosmetic

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3734932A (en) * 1968-01-26 1973-05-22 Y Sakato 1-oxa-8-oxo-2,6,10,10-tetramethyl-spiro-(4,5)-deca-6-ene
JPS518261A (en) * 1974-07-12 1976-01-23 Yoichi Nakatani Arufuaa teasupiranno shinkiseizoho
GB1496098A (en) * 1975-07-30 1977-12-21 Firmenich & Cie Spiranic derivative useful as perfuming and flavour-modifying ingredient

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3734932A (en) * 1968-01-26 1973-05-22 Y Sakato 1-oxa-8-oxo-2,6,10,10-tetramethyl-spiro-(4,5)-deca-6-ene
JPS518261A (en) * 1974-07-12 1976-01-23 Yoichi Nakatani Arufuaa teasupiranno shinkiseizoho
GB1496098A (en) * 1975-07-30 1977-12-21 Firmenich & Cie Spiranic derivative useful as perfuming and flavour-modifying ingredient

Also Published As

Publication number Publication date
JPS601119A (en) 1985-01-07
CH613379A5 (en) 1979-09-28

Similar Documents

Publication Publication Date Title
US4364400A (en) Heterocyclic derivatives as flavoring agents
US4313856A (en) Perfume compositions containing oxygenated ionone derivatives
US4009127A (en) Oxatricyclo compounds useful as perfuming agents
US3968070A (en) Cycloaliphatic compounds as odor- and taste-modifying agents
US4011245A (en) Method for the manufacture of 2,6,10,10-tetramethyl-1-oxaspiro 4,5-dec-6-ene
US4570648A (en) Flavorants containing esters of 2,3,6,6-tetramethylcyclohexenyl carboxylic acids
US4014905A (en) Esters of certain tetramethyl and pentamethyl-1-oxa-spiro [4-5] decan-6-ols with certain alkanoic acids
JPS6240329B2 (en)
US3892809A (en) Process for the preparation of butenoyl 1,3-cyclohexadienes
US4072719A (en) 4-(2,6,6-Trimethyl-2-cyclohexen-1-ylidene)-butan-2-ol
US3931323A (en) Process for the preparation of alkenoyl-substituted cyclohexenes
US3953534A (en) Cycloaliphatic compounds as odour- and taste-modifying agents
CH640706A5 (en) PREPARATION OF MATERIALS AT LEAST MOST OF TRANS, TRANS-DELTA-DAMASCON.
JPS6159317B2 (en)
US4120830A (en) Use of spirane derivatives to improve perfume compositions
US4461309A (en) Ionyl-alkyl and ionyl alkenyl ethers as flavorants for tobacco
US3946080A (en) Flavouring and perfuming ingredients
US4753924A (en) Process for the preparation of 4,4,7-trimethyl-3,4,7,8-tetrahydro-2(6H)-naphthalene-one
US4372881A (en) Unsaturated alicyclic compounds, their use as perfuming and flavoring ingredients
US4132675A (en) CIS-Oct-6-en-1-al perfumes
US4174327A (en) Spirane derivatives
US4003935A (en) 7-Methyl-octahydro-1,4-methano-naphthalen-6-one
US4008184A (en) 6,10 Dimethyl bicyclo(4,4,0)decane or decene alcohol and ester perfume compositions
US3880888A (en) 3,4,7-Trimethyl-2-oxo,-1,6-dioxaspiro(4,5)dec-3-ene
US4192781A (en) Perfumed articles containing cis-oct-6-en-1-al